An overview of the evolution of enterovirus 71 and its clinical and public health significance.
about
Cellular receptors for human enterovirus species aDNA vaccine constructs against enterovirus 71 elicit immune response in miceHighly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidatesIncorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: improved primers for the specific detection of human enterovirus 71 by RT PCRA Conserved Inhibitory Mechanism of a Lycorine Derivative against Enterovirus and Hepatitis C VirusProduction of EV71 vaccine candidatesRole of redox signaling in neuroinflammation and neurodegenerative diseasesInactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic MouseStructures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in ChinaCrystal Structure of Enterovirus 71 RNA-Dependent RNA Polymerase Complexed with Its Protein Primer VPg: Implication for a trans Mechanism of VPg UridylylationThe Enterovirus 71 A-particle Forms a Gateway to Allow Genome Release: A CryoEM Study of Picornavirus UncoatingA sensor-adaptor mechanism for enterovirus uncoating from structures of EV71A Strain-Specific Epitope of Enterovirus 71 Identified by Cryo-Electron Microscopy of the Complex with Fab from Neutralizing AntibodyTherapeutic and prevention strategies against human enterovirus 71 infectionHuman SCARB2-mediated entry and endocytosis of EV71Immunological and biochemical characterization of coxsackie virus A16 viral particlesThe interplays between autophagy and apoptosis induced by enterovirus 71Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal AntibodyHand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.PolyC-binding protein 1 interacts with 5'-untranslated region of enterovirus 71 RNA in membrane-associated complex to facilitate viral replication.Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylationEffective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activityAnimal models of enterovirus 71 infection: applications and limitations.Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery.Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis.Clinical and epidemiological characteristics of adult hand, foot, and mouth disease in northern Zhejiang, China, May 2008-November 2013.Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses.Coxsackievirus A6 and hand, foot, and mouth disease, Finland.Dynamic Interaction of Enterovirus 71 and Dendritic Cells in Infected Neonatal Rhesus MacaquesAntiviral activities of Schizonepeta tenuifolia Briq. against enterovirus 71 in vitro and in vivo.UGGT1 enhances enterovirus 71 pathogenicity by promoting viral RNA synthesis and viral replicationConcentration and purification of enterovirus 71 using a weak anion-exchange monolithic column.The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71.Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn miceElucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profilingTyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection.Expression, purification and characterization of enterovirus-71 virus-like particles.Fatal case of enterovirus 71 infection, France, 2007.Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.
P2860
Q21131148-9583574A-8162-481E-8E5D-70EC85DEC8EAQ21245503-61634AB3-158C-4EDB-80E6-A4CB82CF8B4AQ24657870-8A8CCF61-7FF6-4DB6-B46E-54EE64EEF13AQ24800087-ABAD270E-FB4E-4B7E-B68D-8E5399A3E5BCQ26700115-D03C920E-3A84-4A7F-9666-4CBF2CA36F81Q26866091-1125745A-363B-446D-9150-3FE683C6F6DEQ27012569-B0DE0DED-2093-49E2-A585-B029218C12E3Q27321616-214A5A70-7E02-44F2-8560-B541E0C351F1Q27666460-04CC1581-9D56-493B-88C1-7687D8108CA7Q27676806-88FFBA16-E3CA-45DA-A69D-EF30C979171DQ27677204-48ABB418-64A9-42AC-8FC2-5147D3336DA4Q27677825-F45ED13E-E369-4D28-8F94-BD50508C42D2Q27679681-187D2D0A-12FA-4471-B129-5D39C1F05A71Q28080796-2E27BAE0-85D9-497D-B65B-6155DBBE1830Q28478931-0F8591A3-6D0F-4DE8-9E23-AB41978C006CQ28485432-3D8E81D7-4A52-437D-B8C2-622A47B55B9BQ28486246-C2B76B73-F418-421B-8A97-A06E929FD93AQ28550496-8160BCD9-8E44-4BE6-8571-DF73475DB3B1Q30249022-81041C35-4A05-4D57-BEAB-E50D418618BEQ31056961-E01EB656-5FE4-4A60-8D11-C47C2B88903CQ31149456-9061B1D1-30C0-4E08-92E3-96A87989F718Q33506618-490D9B59-28E4-464C-8B18-B18137090AB4Q33576597-CAC03CCB-44F2-4AB3-929E-6D092E951503Q33579809-7ABE8960-D277-425E-88B8-C83069D73C89Q33611044-83E709F6-8478-4EEC-951C-9A614FF0EC32Q33627625-F68C5811-66B3-4273-A94E-F7CE31AE467CQ33634281-33F72EC6-2FBC-4079-A179-B9A2B3ED28C5Q33643774-7447D195-6FB9-4056-9BEB-1E440CBEF52BQ33644605-C0CB25DF-712C-4CC5-887E-FDE2B6E2F633Q33653696-A9B184A1-42F7-4EFE-B0B5-ABFCEDDC1E1BQ33681457-69CE4C84-1393-4231-98CA-6ADCFCD4A321Q33699539-81A51FC6-E564-4962-9E8C-656F5071AFA1Q33701681-81786BB0-5FDC-4F70-9080-3DA8E7EEC621Q33721725-11D12D25-755C-4DFB-8DAB-614F4A198DBEQ33723474-8C4B4FCC-CB52-4D2C-A689-CB28D1C25C94Q33729001-E3CCE0E8-D03C-4DBF-9605-46CB12A699A7Q33747574-332575F3-4704-4FFF-999A-688A5E763D34Q33788579-716F6980-0715-49F8-97FD-EA87EC1B203DQ33800653-9AA2B58E-72D7-4941-95BB-E9C79D0AB529Q33806668-6E173449-81C2-427E-B836-CF50F4CDD572
P2860
An overview of the evolution of enterovirus 71 and its clinical and public health significance.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An overview of the evolution o ...... nd public health significance.
@ast
An overview of the evolution o ...... nd public health significance.
@en
An overview of the evolution o ...... nd public health significance.
@nl
type
label
An overview of the evolution o ...... nd public health significance.
@ast
An overview of the evolution o ...... nd public health significance.
@en
An overview of the evolution o ...... nd public health significance.
@nl
prefLabel
An overview of the evolution o ...... nd public health significance.
@ast
An overview of the evolution o ...... nd public health significance.
@en
An overview of the evolution o ...... nd public health significance.
@nl
P1476
An overview of the evolution o ...... nd public health significance.
@en
P2093
Peter C McMinn
P304
P356
10.1111/J.1574-6976.2002.TB00601.X
P577
2002-03-01T00:00:00Z